why choose us

First received: October 31, 2024

Clinical Trial: Phase I Single-blind Clinical Trial to Evaluate the Safety and Local Immune Activation of a Toll-like Receptor 5 Agonist (FLAMOD) Administered by Aerosol

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Pneumonia

Study Type: INTERVENTIONAL


Official Title: Phase I Single-blind Clinical Trial to Evaluate the Safety and Local Immune Activation of a Toll-like Receptor 5 Agonist (FLAMOD) Administered by Aerosol

Brief Summary: This is a single-blind, randomized, placebo-controlled, dose-escalation phase I monocentric trial assessing a single administration of FLAMOD by aerosol in healthy subjects.The recruitment is performed by the Clinical Investigation Center of Tours.This trial is divided in two stages:the "start-up phase" consisting of a dose escalation to ensure the safety of FLAMOD while allowing sufficient information on the molecule activity to be accumulatedthe dose-finding phase estimating several dose-activity…

Read more